|
[1]CERQUEIRA C,MANFROI B,FILLATREAU S.IL-10-producing regulatory B cells and plasmocytes:Molecular mechanisms and disease relevance[J].Semin Immunol,2019,44:101323．
|
|
[2]W SIK M,NAZIMEK K,BRYNIARSKI K.Regulatory B cell phenotype and mechanism of action:the impact of stimulating conditions[J].Microbiol Immunol,2018,62(8):485-496．
|
|
[3]LIU X,JIANG X,LIU R,et al.B cells expressing CD11b effectively inhibit CD4+T-cell responses and ameliorate experimental autoimmune hepatitis in mice[J].Hepatology,2015,62(5):1563-1575．
|
|
[4]BELAND K,MARCEAU G,LABARDY A,et al.Depletion of Bcells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells[J].Hepatology,2015,62(5):1511-1523．
|
|
[5]KATZ SI,PARKER D,TURK JL.B-cell suppression of delayed hypersensitivity reactions[J].Nature,1974,251(5475):550-551．
|
|
[6]WOLF SD,DITTEL BN,HARDARDOTTIR F,et al.Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice[J].J Exp Med,1996,184(6):2271-2278．
|
|
[7]MIZOGUCHI E,MIZOGUCHI A,PREFFER FI,et al.Regulatory role of mature B cells in a murine model of inflammatory bowel disease[J].Int Immunol,2000,12(5):597-605．
|
|
[8]YANABA K,BOUAZIZ JD,HAAS KM,et al.A regulatory B cell subset with a unique CD1dhiCD5+phenotype controls T cell-dependent inflammatory responses[J].Immunity,2008,28(5):639-650．
|
|
[9]BLAIR PA,NOREA LY,FLORES-BORJA F,et al.CD19(+)CD24(hi)CD38(hi)B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients[J].Immunity,2010,32(1):129-140．
|
|
[10]RINCN-ARVALO H,SANCHEZ-PARRA CC,CASTAO D,et al.Regulatory B cells and mechanisms[J].Int Rev Immunol,2016,35(2):156-176．
|
|
[11]FENG JS,CHI HG,ZHENG XB.Phenotype and related functional molecules of regulatory B cells in human body[J].Chin J Cell Mol Immunol,2013,29(3):320-323,327.(in Chinese)冯锦山，迟宏罡，郑学宝．人体调节性B细胞表型及相关功能分子研究[J]．细胞与分子免疫学杂志，2013,29(3):320-323,327．
|
|
[12]TEDDER TF.B10 cells:A functionally defined regulatory B cell subset[J].J Immunol,2015,194(4):1395-1401．
|
|
[13]MATSUMOTO M,BABA A,YOKOTA T,et al.Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation[J].Immunity,2014,41(6):1040-1051．
|
|
[14]van de VEEN W,STANIC B,YAMAN G,et al.Ig G4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses[J].J Allergy Clin Immunol,2013,131(4):1204-1212．
|
|
[15]SATTLER S,LING GS,XU D,et al.IL-10-producing regulatory B cells induced by IL-33(Breg(IL-33))effectively attenuate mucosal inflammatory responses in the gut[J].J Autoimmun,2014,50:107-122．
|
|
[16] XIAO X,LAO XM,CHEN MM,et al.PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression[J].Cancer Discov,2016,6(5):546-559．
|
|
[17]NOVA-LAMPERTI E,FANELLI G,BECKER PD,et al.IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses[J].Sci Rep,2016,6:20044．
|
|
[18]WEI B,DENG Y,HUANG Y,et al.IL-10-producing B cells attenuate cardiac inflammation by regulating Th1 and Th17 cells in acute viral myocarditis induced by coxsackie virus B3[J].Life Sci,2019,235:116838．
|
|
[19]YANG M,SUN L,WANG S,et al.Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells[J].J Immunol,2010,184(7):3321-3325．
|
|
[20]NOUL A,POCHARD P,SIMON Q,et al.B-Cells induce regulatory T cells through TGF-β/IDO production in A CTLA-4 dependent manner[J].J Autoimmun,2015,59:53-60．
|
|
[21]HUSSAIN S,DELOVITCH TL.Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner[J].J Immunol,2007,179(11):7225-7232．
|
|
[22] SHEN P,ROCH T,LAMPROPOULOU V,et al.IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases[J].Nature,2014,507(7492):366-370．
|
|
[23]WANG K,TAO L,SU J,et al.TLR4 supports the expansion of Fas L+CD5+CD1dhiregulatory B cells,which decreases in contact hypersensitivity[J].Mol Immunol,2017,87:188-199．
|
|
[24]TIAN J,ZEKZER D,HANSSEN L,et al.Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice[J].J Immunol,2001,167(2):1081-1089．
|
|
[25]WANG X,WANG G,WANG Z,et al.PD-1-expressing B cells suppress CD4+and CD8+T cells via PD-1/PD-L1-dependent pathway[J].Mol Immunol,2019,109:20-26．
|
|
[26]MEILER S,SMEETS E,WINKELS H,et al.Constitutive GITR activation reduces atherosclerosis by promoting regulatory CD4+T-Cell responses-brief report[J].Arterioscler Thromb Vasc Biol,2016,36(9):1748-1752．
|
|
[27]SEBODE M,HARTL J,VERGANI D,et al.Autoimmune hepatitis:From current knowledge and clinical practice to future research agenda[J].Liver Int,2018,38(1):15-22．
|
|
[28]ZHANG J,WANG QX,MA X.Advances in immunological treatment of autoimmune hepatitis[J].J Clin Hepatol,2016,32(10):1874-1877.(in Chinese)张珺，王绮夏，马雄．自身免疫性肝炎免疫学治疗进展[J]．临床肝胆病杂志，2016,32(10):1874-1877．
|
|
[29]SUCHER E,SUCHER R,GRADISTANAC T,et al.Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies[J].J Immunol Res,2019,2019:9437043．
|
|
[30]WANG WZ,XIANG XX.Immunological mechanism of Treg/Th17 and Th1/Th2 balance in autoimmune hepatitis and new targets for diagnosis and treatment[J].J Clin Hepatol,2019,35(8):1874-1877.(in Chinese)王维钊，向晓星．Treg/Th17、Th1/Th2平衡在自身免疫性肝炎中的免疫学机制及诊疗新靶点[J]．临床肝胆病杂志，2019,35(8):1874-1877．
|
|
[31]MA L,ZHANG LW,ZHUANG Y,et al.Exploration the significance of Tfh and related molecules on C57BL/6 mice model of experimental autoimmune hepatitis[J].J Microbiol Immunol Infect,2019.[Online ahead of print]
|
|
[32]TIAN JJ.Study on the characteristic of B cell Subsets in autoimmune hepatitis[D].Tianjin:Tianjin Medical University,2018:9-17.(in Chinese)田佳骏．自身免疫性肝炎B细胞亚群特点研究[D]．天津:天津医科大学，2018:9-17．
|
|
[33]XIAO S,BROOKS CR,SOBEL RA,et al.Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation[J].J Immunol,2015,194(4):1602-1608.
|
DownLoad: